With passion for patients and science, the Marinomed team is proud of its track record of successful product and drug development in respiratory, infectious, immunological, and ophthalmic diseases. As it is our ambition to transform the lives of patients we seek to work with strategic partners that join us on this journey.
Marinomed has been successfully represented on the market for several years with its existing portfolio of OTC products to treat cold viruses. Currently, we collaborate with 17 commercialisation partners for more than 40 countries.
The Carragelose® platform is protected by several patent families and the Marinosolv® technology platform has been registered as a patent in all internationally important target markets.